View in EDS HTML Full Text PDF Full Text

Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.

Saved in:
Bibliographic Details
Title: Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.
Authors: Fazio M; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA., van Rooijen E; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA., Mito JK; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Modhurima R; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Weiskopf E; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Yang S; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Zon LI; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA.
Source: Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2021 May; Vol. 34 (3), pp. 641-647. Date of Electronic Publication: 2020 Nov 17.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33064882
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Fazio+M%22">Fazio M</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22van+Rooijen+E%22">van Rooijen E</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mito+JK%22">Mito JK</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Modhurima+R%22">Modhurima R</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Weiskopf+E%22">Weiskopf E</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+S%22">Yang S</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zon+LI%22">Zon LI</searchLink>; Stem Cell Program and the Division of Pediatric Hematology/Oncology, Howard Hughes Medical Institute, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Cambridge, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101318927%22">Pigment cell & melanoma research</searchLink> [Pigment Cell Melanoma Res] 2021 May; Vol. 34 (3), pp. 641-647. <i>Date of Electronic Publication: </i>2020 Nov 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Blackwell+Munksgaard%22">Blackwell Munksgaard </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101318927 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1755-148X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217551471%22">17551471 </searchLink><i>NLM ISO Abbreviation: </i>Pigment Cell Melanoma Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33064882
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/pcmr.12937
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 641
    Titles:
      – TitleFull: Recurrent co-alteration of HDGF and SETDB1 on chromosome 1q drives cutaneous melanoma progression and poor prognosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fazio M
      – PersonEntity:
          Name:
            NameFull: van Rooijen E
      – PersonEntity:
          Name:
            NameFull: Mito JK
      – PersonEntity:
          Name:
            NameFull: Modhurima R
      – PersonEntity:
          Name:
            NameFull: Weiskopf E
      – PersonEntity:
          Name:
            NameFull: Yang S
      – PersonEntity:
          Name:
            NameFull: Zon LI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2021 May
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1755-148X
          Numbering:
            – Type: volume
              Value: 34
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Pigment cell & melanoma research
              Type: main
ResultId 1